Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Teradyne, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.52 (market cap $8.47B), while Teradyne, Inc. trades at $345.06 (market cap $56.20B). The key difference: Teradyne, Inc. is far larger — about 6.6× Hinge Health Inc. Class A Common Stock's market cap, and Teradyne, Inc. pays a 0.14% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Teradyne, Inc. for 37 Days on average.
| HNGE | TER | |
|---|---|---|
Market Cap | $8.47B | $56.20B |
Volume | 1,624,526 | 3,754,298 |
Sector | Health | Technology |
52-Week High | $105.14 | $483.84 |
52-Week Low | $31.17 | $138.09 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $8.09B | $55.94B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Teradyne (TER) trades at $380.29, down 0.93% on the day, with a bearish technical signal as it tests support near $378. The stock shows strong fundamentals with three consecutive quarterly EPS beats and robust profitability margins, including a 25.77% net income margin. Recent news highlights expansion in AI-driven memory test systems and a strategic partnership with GSME, positioning the company in high-growth semiconductor markets. Analyst consensus remains optimistic with a $461.50 price target and no sell ratings among 31 analysts.
The outlook for TER is positive due to strong earnings momentum and strategic positioning in AI and semiconductor testing, though elevated valuation ratios like a P/E of 49.37 pose a risk if growth slows. Key risks include competitive pressures from KLAC and COHU, cyclical semiconductor demand, and insider selling activity. Institutional interest remains strong, supporting a moderate buy recommendation for long-term investors focused on tech infrastructure growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
